Clinical trial
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
NCT00997438 is registered in ClinicalTrials.gov with Portland VA Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
- Lead sponsor
- Portland VA Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- December 31, 2013
- Enrollment
- 69 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.